Helicobacter pylori infection in pediatric population: epidemiology, pathophysiology, and therapy

Area of Science:

• Microbiology
• Infectious Diseases
• Gastroenterology

Background:

• Helicobacter pylori is a prevalent human pathogen affecting over half of adults and children.
• H. pylori infection is frequently linked to chronic gastritis and peptic ulcer disease, particularly in children.
• Infection prevalence and early colonization are higher in developing countries compared to developed ones.

Purpose of the Study:

• To review the prevalence, diagnosis, and treatment of Helicobacter pylori infections.
• To highlight the challenges posed by H. pylori, including asymptomatic cases and rising drug resistance.
• To discuss current and potential therapeutic strategies for H. pylori eradication.

Main Methods:

• Review of current diagnostic methods including histology, culture, urease tests, PCR, and stool antigen detection.
• Analysis of clinical presentations, ranging from asymptomatic to symptoms like nausea, vomiting, and epigastric pain.
• Evaluation of treatment outcomes, focusing on combination therapies for optimal eradication rates.

Main Results:

• H. pylori is a leading cause of chronic gastritis and peptic ulcer disease in children.
• Combination therapy with a proton-pump inhibitor and two antibiotics offers the best eradication rates.
• Antibiotic resistance in H. pylori is an increasing challenge, limiting treatment options.

Conclusions:

• Effective H. pylori eradication relies on appropriate antibiotic and proton-pump inhibitor combinations.
• The growing issue of drug resistance necessitates ongoing research into new therapeutic approaches.
• Early diagnosis and treatment are crucial, especially given the high prevalence in childhood and developing nations.